850 related articles for article (PubMed ID: 25869441)
41. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.
Larsson LG
Semin Cancer Biol; 2011 Dec; 21(6):367-76. PubMed ID: 22037160
[TBL] [Abstract][Full Text] [Related]
42. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
43. Hallmarks of senescence in carcinogenesis and cancer therapy.
Shay JW; Roninson IB
Oncogene; 2004 Apr; 23(16):2919-33. PubMed ID: 15077154
[TBL] [Abstract][Full Text] [Related]
44. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells.
Kim H; You S; Farris J; Kong BW; Christman SA; Foster LK; Foster DN
Exp Cell Res; 2002 Jan; 272(2):199-208. PubMed ID: 11777345
[TBL] [Abstract][Full Text] [Related]
45. Senescence; an endogenous anticancer mechanism.
Vargas J; Feltes BC; Poloni Jde F; Lenz G; Bonatto D
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2616-43. PubMed ID: 22652801
[TBL] [Abstract][Full Text] [Related]
46. Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells.
Ramirez RD; Herbert BS; Vaughan MB; Zou Y; Gandia K; Morales CP; Wright WE; Shay JW
Oncogene; 2003 Jan; 22(3):433-44. PubMed ID: 12545164
[TBL] [Abstract][Full Text] [Related]
47. Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS.
Klimova TA; Bell EL; Shroff EH; Weinberg FD; Snyder CM; Dimri GP; Schumacker PT; Budinger GR; Chandel NS
FASEB J; 2009 Mar; 23(3):783-94. PubMed ID: 18948382
[TBL] [Abstract][Full Text] [Related]
48. Telomerase, senescence and ageing.
Shawi M; Autexier C
Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
[TBL] [Abstract][Full Text] [Related]
49. Cell senescence and cancer.
Mathon NF; Lloyd AC
Nat Rev Cancer; 2001 Dec; 1(3):203-13. PubMed ID: 11902575
[TBL] [Abstract][Full Text] [Related]
50. Fighting Carcinogenesis with Plant Metabolites by Weakening Proliferative Signaling and Disabling Replicative Immortality Networks of Rapidly Dividing and Invading Cancerous Cells.
Wani AK; Akhtar N; Sharma A; El-Zahaby SA
Curr Drug Deliv; 2023; 20(4):371-386. PubMed ID: 35422214
[TBL] [Abstract][Full Text] [Related]
51. Cellular senescence in the development and treatment of cancer.
Saretzki G
Curr Pharm Des; 2010 Jan; 16(1):79-100. PubMed ID: 20214620
[TBL] [Abstract][Full Text] [Related]
52. Genes and pathways involved in senescence bypass identified by functional genetic screens.
Roupakia E; Markopoulos GS; Kolettas E
Mech Ageing Dev; 2021 Mar; 194():111432. PubMed ID: 33422562
[TBL] [Abstract][Full Text] [Related]
53. Cellular senescence: a hitchhiker's guide.
Aravinthan A
Hum Cell; 2015 Apr; 28(2):51-64. PubMed ID: 25690721
[TBL] [Abstract][Full Text] [Related]
54. Exploiting tumor cell senescence in anticancer therapy.
Lee M; Lee JS
BMB Rep; 2014 Feb; 47(2):51-9. PubMed ID: 24411464
[TBL] [Abstract][Full Text] [Related]
55. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
[No Abstract] [Full Text] [Related]
56. Living Beyond Restriction: LBR promotes cellular immortalization by suppressing genomic instability and senescence.
Choi H; Kang C
FEBS J; 2024 May; 291(10):2091-2093. PubMed ID: 38646863
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity.
Guillon J; Petit C; Toutain B; Guette C; Lelièvre E; Coqueret O
Cell Cycle; 2019 Oct; 18(19):2385-2397. PubMed ID: 31397193
[TBL] [Abstract][Full Text] [Related]
58. The impact of cellular senescence in cancer therapy: is it true or not?
Zhang Y; Yang JM
Acta Pharmacol Sin; 2011 Oct; 32(10):1199-207. PubMed ID: 21909124
[TBL] [Abstract][Full Text] [Related]
59. [Contribution to tumor escape and chemotherapy response: A choice between senescence and apoptosis in heterogeneous tumors].
Jonchère B; Vétillard A; Toutain B; Guette C; Coqueret O
Bull Cancer; 2016 Jan; 103(1):73-86. PubMed ID: 26762946
[TBL] [Abstract][Full Text] [Related]
60. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.
Saleh T; Carpenter VJ; Bloukh S; Gewirtz DA
Semin Cancer Biol; 2022 Jun; 81():37-47. PubMed ID: 33358748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
